Rapid Antibiotic Susceptibility Testing via Single Dye Flow Cytometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial susceptibility testing methods are lengthy and labor-intensive, often requiring 2-7 days to determine the appropriate antibiotic therapy for bacterial infections, which can lead to suboptimal treatment and increased mortality rates due to antibiotic resistance and delayed diagnosis.
Innovation Solution
A method involving preparing bacterial suspensions with varying antimicrobial agent concentrations, incubating them, and using a single fluorescent membrane-associated dye to measure spectral intensity ratios through flow cytometry, allowing for rapid determination of minimum inhibitory concentration and antibiotic susceptibility within hours.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional culture-based antimicrobial susceptibility testing is used, then accurate pathogen identification and sensitivity determination are achieved, but the testing time is excessively long (2-7 days)
Solution Approach 1:
The patent extracts the critical measurement step from the lengthy culture process. By using flow cytometry to detect and analyze bacterial cells directly from clinical samples, the method eliminates the need for extended cultural isolation while maintaining identification accuracy through fluorescent spectral analysis of bacterial cell properties
Solution Approach 2:
The patent replaces the mechanical/biological culture system with an optical detection system. Flow cytometry with fluorescent staining substitutes the time-consuming bacterial culture and observation process, enabling rapid characterization of bacterial cells based on their optical properties rather than requiring days of growth
2Reliability
If traditional step-by-step isolation and testing process is followed, then reliable antibiotic susceptibility results are obtained, but the process is labor-intensive and complex
Solution Approach 1:
The patent merges multiple separate testing steps into a single integrated flow cytometry assay. Bacterial detection, characterization, and antibiotic susceptibility assessment are combined into one automated measurement process, eliminating the need for separate isolation, culture, and testing stages while maintaining result reliability
Solution Approach 2:
The flow cytometry system serves multiple functions simultaneously: it detects bacterial presence, characterizes bacterial types, and assesses antibiotic susceptibility. This multi-functional approach replaces the traditional specialized equipment and procedures required for each separate testing step
3Manufacturing precision
If extended incubation and culture periods are used, then complete bacterial growth for accurate testing is achieved, but patient treatment is significantly delayed
Solution Approach 1:
The patent performs preliminary bacterial characterization and susceptibility assessment directly from the clinical sample without waiting for complete bacterial growth. By using fluorescent markers that bind to bacterial cell components, the method obtains diagnostic information in hours rather than requiring days of incubation for full bacterial development
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the time to determine antibiotic susceptibility and minimum inhibitory concentration, enabling timely and effective treatment, improving patient outcomes and addressing antibiotic resistance challenges.
Implementation Method 1
a single dye that is a fluorescent membrane-associated dye that incorporates into a lipid bilayer
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Single dye fluorescent staining and the combination of differences in both intensity and spectral emission permit determination of the minimum concentration of an antibiotic needed to inactivate bacteria (Minimum Inhibitory Concentration (MIC)), thereby providing a means for rapid Antibiotic Susceptibility Testing (AST). This allows for a quick and easy means for clinicians to determine a suitable treatment regimen for patients suffering from bacterial infections and those that eventually lead to sepsis.